Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Blocking JAK1/JAK2 While Sparing JAK3 Not Only Prevents GvHD but Also Promotes Damaged Tissue Repair

Kidist Ashami, BA, Sena Kim, PhD, Ravi Vij, MBBS, Julie K. Ritchey, Srikanth Santhanam, PhD, Sora Lim, MS, Sarah Peterson, Matthew Ciorba, MD, John F. DiPersio, MD PhD, Jaebok Choi, PhD

Blood (2019) 134 (Supplement_1): 4420.

https://doi.org/10.1182/blood-2019-126167

Published: 2019

Journal Articles

Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy

Karl W. Staser, MD PhD, Matthew L. Cooper, PhD, Jaebok Choi, PhD, Anand Chukka, Kidist Ashami, BA, Jessica Niswonger, Jaehan Park, Byung Ha Lee, PhD, Shunqiang Li, PhD, Amanda F Cashen, MD, Amy Musiek, MD, John F. DiPersio, MD PhD

Blood (2018) 132 (Supplement 1): 340.

https://doi.org/10.1182/blood-2018-99-119375

Published: 2018

Journal Articles

Baricitinib Prevents and Treats GvHD through Both Immune Modulation and Enhancement of Tissue Repair

Kidist Ashami, BA, Kiran R. Vij, MD, Julie Ritchey, Srikanth Santhanam, PhD, Karl W. Staser, MD PhD, Sora Lim, Sena Kim, Matthew L. Cooper, PhD, Feng Gao, PhD, Matthew Ciorba, John F. DiPersio, MD PhD, Jaebok Choi, PhD

Blood (2018) 132 (Supplement 1): 3311.

https://doi.org/10.1182/blood-2018-99-119470

Published: 2018

Journal Articles

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 844.

https://doi.org/10.1182/blood.V130.Suppl_1.844.844

Published: 2017

Journal Articles

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Bader Alahmari, MD, Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Julie Ritchey, Bing Wang, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3344.

https://doi.org/10.1182/blood.V128.22.3344.3344

Published: 2016

Journal Articles

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Bing Wang, Julie Ritchey, Bader Alahmari, MD, Matthew Holt, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3353.

https://doi.org/10.1182/blood.V128.22.3353.3353

Published: 2016

Journal Articles

Targeting Alpha 4 Integrin (CD49d) to Reduce GvHD

Bader Alahmari, MBBS, Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2015) 126 (23): 4283.

https://doi.org/10.1182/blood.V126.23.4283.4283

Published: 2015

Journal Articles

A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results

Mark A. Schroeder, MD, Jaebok Choi, PhD, Matthew L Cooper, PhD, David Schwab, BA CCRP, Sarah Willey, Jingxia (Esther) Liu, PhD, Matthew Holt, Linda Eissenberg, Iskra Pusic, MD, Armin Ghobadi, MD, Rizwan Romee, MD, John S. Welch, MD PhD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Ravi Vij, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, John F Dipersio, MD PhD

Blood (2015) 126 (23): 1935.

https://doi.org/10.1182/blood.V126.23.1935.1935

Published: 2015

Journal Articles

Dysregulated Overexpression of S100A8 and S100A9 Calgranulin Family Proteins in IFNγR-/- Allogeneic T Cells Is Associated with Reduced Graft Versus Host Disease in Vivo

Matthew L Cooper, PhD, Jaebok Choi, PhD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2014) 124 (21): 3828.

https://doi.org/10.1182/blood.V124.21.3828.3828

Published: 2014

Journal Articles

Targeting VLA-4 to Reduce GvHD

Jaebok Choi, PhD, Matthew L Cooper, PhD, Bader Alahmari, MD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2014) 124 (21): 3829.

https://doi.org/10.1182/blood.V124.21.3829.3829

Published: 2014

Journal Articles

Maintenance Therapy With Decitabine After Allogeneic Hematopoietic Stem Cell Transplantation For Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Iskra Pusic, MD, Jaebok Choi, PhD, Noel Bernabe, Camille N. Abboud, MD, Peter Westervelt, MD, PhD, Ravi Vij, MD, Amanda F Cashen, MD, Geoffrey L. Uy, MD, Keith E. Stockerl-Goldstein, MD, John F. Dipersio, MD, PhD

Blood (2013) 122 (21): 4638.

https://doi.org/10.1182/blood.V122.21.4638.4638

Published: 2013

Journal Articles

IFNγR Signaling As a Therapeutic Target To Prevent GvHD While Preserving Gvl

Jaebok Choi, PhD, Matthew L Cooper, PhD, Julie Ritchey, Lynne Collins, Julie Prior, David Piwnica-Worms, MD, PhD, John F. Dipersio, MD, PhD

Blood (2013) 122 (21): 4464.

https://doi.org/10.1182/blood.V122.21.4464.4464

Published: 2013

Journal Articles

Defining The Mechanism Involved In The Inhibition Of GvHD By Azacytidine In Vivo Through The Use Of FoxP3 Diphtheria Toxin Receptor ( Foxp3 DTR ) Donor T Cells

Matthew L Cooper, PhD, Jaebok Choi, PhD, Julie Ritchey, John F. DiPersio, MD, PhD

Blood (2013) 122 (21): 134.

https://doi.org/10.1182/blood.V122.21.134.134

Published: 2013

Journal Articles

Interruption of IFNγR Signaling Results in Altered T Cell Trafficking in Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Jaebok Choi, PhD., Edward Dela Ziga, MD, MPH, Julie Ritchey, Lynne Collins, Julie Prior, Matthew Cooper, PhD, David Piwnica-Worms, MD, PhD, John F. DiPersio, MD, PhD

Blood (2012) 120 (21): 455.

https://doi.org/10.1182/blood.V120.21.455.455

Published: 2012

Journal Articles

Use of FoxP3 Diptheria Toxin Receptor ( Foxp3 DTR ) Donor T Cells to Define the Mechanism Involved in the Inhibition of GvHD by Azacytidine in Vivo

Matthew L Cooper, PhD, Jaebok Choi, PhD., Julie Ritchey, John F. DiPersio, MD, PhD

Blood (2012) 120 (21): 4113.

https://doi.org/10.1182/blood.V120.21.4113.4113

Published: 2012

Journal Articles

Interruption of the IFN γR/CXCR3 Axis Results in Altered T Cell Trafficking In Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Jaebok Choi, PhD., Edward Dela Ziga, MD, MPH, Julie Ritchey, Julie Prior, Lynne Collins, Johnny Wei, David Piwnica-Worms, MD, PhD, John F. DiPersio, MD, PhD

Blood (2011) 118 (21): 2971.

https://doi.org/10.1182/blood.V118.21.2971.2971

Published: 2011

Journal Articles

Effect of a Novel Nucleoside Analogue, Triciribine Phosphate (TCN-P) on Murine Acute Graft-Vrs-Host Disease (aGvHD)

Edward Dela Ziga, MD, MPH, Jaebok Choi, PhD., Mark Needles, Julie Ritchey, John F. DiPersio, MD, PhD

Blood (2011) 118 (21): 2977.

https://doi.org/10.1182/blood.V118.21.2977.2977

Published: 2011

Journal Articles

SiglecH Positive Myeloid Cells Mobilized by Pegylated Murine GM-CSF Have Potent Allo-Suppressive Properties In Vitro .

Mark A. Schroeder, MD, Jaebok Choi, PhD., Satheesh K. Sainathan, Brian K Dieckgraefe, M.D., PhD., John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 1459.

https://doi.org/10.1182/blood.V116.21.1459.1459

Published: 2010

Journal Articles

Effect of In Vivo Azacitidine on GvHD and Gvl: Mechanistic Studies

Jaebok Choi, PhD., Julie Ritchey, Jessica Su, Julie Prior, Edward Ziga, David Piwnica-Worms, John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 2537.

https://doi.org/10.1182/blood.V116.21.2537.2537

Published: 2010

Journal Articles

Epigenetic Control of GvHD and Gvl Using the Hypomethylating Agent Azacitidine.

Jaebok Choi, PhD, Julie Ritchey, John F. DiPersio, MD, PhD

Blood (2009) 114 (22): 2447.

https://doi.org/10.1182/blood.V114.22.2447.2447

Published: 2009

NARROW

Blocking JAK1/JAK2 While Sparing JAK3 Not Only Prevents GvHD but Also Promotes Damaged Tissue Repair

Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy

Baricitinib Prevents and Treats GvHD through Both Immune Modulation and Enhancement of Tissue Repair

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Targeting Alpha 4 Integrin (CD49d) to Reduce GvHD

A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results

Dysregulated Overexpression of S100A8 and S100A9 Calgranulin Family Proteins in IFNγR-/- Allogeneic T Cells Is Associated with Reduced Graft Versus Host Disease in Vivo

Targeting VLA-4 to Reduce GvHD

Maintenance Therapy With Decitabine After Allogeneic Hematopoietic Stem Cell Transplantation For Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

IFNγR Signaling As a Therapeutic Target To Prevent GvHD While Preserving Gvl

Defining The Mechanism Involved In The Inhibition Of GvHD By Azacytidine In Vivo Through The Use Of FoxP3 Diphtheria Toxin Receptor ( Foxp3 DTR ) Donor T Cells

Interruption of IFNγR Signaling Results in Altered T Cell Trafficking in Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Use of FoxP3 Diptheria Toxin Receptor ( Foxp3 DTR ) Donor T Cells to Define the Mechanism Involved in the Inhibition of GvHD by Azacytidine in Vivo

Interruption of the IFN γR/CXCR3 Axis Results in Altered T Cell Trafficking In Vivo and Abrogation of GvHD While Maintaining a Robust Gvl Response

Effect of a Novel Nucleoside Analogue, Triciribine Phosphate (TCN-P) on Murine Acute Graft-Vrs-Host Disease (aGvHD)

SiglecH Positive Myeloid Cells Mobilized by Pegylated Murine GM-CSF Have Potent Allo-Suppressive Properties In Vitro .

Effect of In Vivo Azacitidine on GvHD and Gvl: Mechanistic Studies

Epigenetic Control of GvHD and Gvl Using the Hypomethylating Agent Azacitidine.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only